BillionToOne (BLLN) Notes Payables (2025 - 2026)

BillionToOne (BLLN) posted Notes Payables of $8.9 million for Q1 2026, down 3.86% sequentially from $9.3 million in Q4 2025.

BillionToOne (BLLN) Notes Payables (2025 - 2026) Analysis & Trends

BillionToOne has reported Notes Payables for 2 years, with the latest figure at $8.9 million in Q1 2026.

  • Quarterly Notes Payables changed N/A year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (changed N/A YoY) and the FY2025 annual result came in at $9.3 million, changed N/A from the prior year.
  • Notes Payables retreated to $8.9 million in Q1 2026 per BLLN's latest filing, from $9.3 million in the prior quarter.
  • Over five years, Notes Payables peaked at $9.3 million in Q4 2025 and troughed at $8.9 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn
10 BillionToOne 6.88 Bn 6.34 Bn 79.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.92 Mn
Dec 31, 2025 9.28 Mn